MIMETAS Contributes With Human Organ-on-Chip Data to IND Application by Argenx
MIMETAS announced an Investigational New Drug (IND) filing by argenx and was supported by data from MIMETAS.
July 12, 2024
by Biotech Newswire
New Progress of Key Chinese COVID-19 Drugs under Research
With the wide spread of Delta mutant worldwide, the COVID-19 infection situation is worrisome. In addition to vaccination for prevention, drug therapy can alleviate the disease deterioration...
October 28, 2021
by PharmaSources/Xiaoyaowan
Govt extends validity of import licence & registration certificate by six months
With an aim to ensure the availability of medicines amidst the prevailing corona virus in the country, the government has given an extension of six months for the validity of import licence (Form-10).
November 30, 2020
by expresspharma
Demand for repurposed drugs to continue even after launch of COVID-19 vaccines: Experts
Due to the large size of the population in the country and anticipated challenges associated with the COVID-19 vaccine supply chain, it will take considerable time until the entire nation gets vaccinated.
November 24, 2020
by expresspharma
Drug Safety Research Unit says repurposed drugs for COVID-19 still require a lot of testing
The DSRU said that global collaboration would be required to successfully expedite the necessary safety and efficacy evaluations for repurposed drugs to be used in COVID-19 patients.
November 19, 2020
by europeanpharmaceuticalreview
Fall clause does not apply on the sale of drugs which have an expiry date: DoP
The Department of Pharmaceuticals (DoP) has issued a letter informing the Ministries/Departments involved in the procurement of drugs through agencies that fall clause does not apply on the sale of drugs, which have an expiry date.
November 17, 2020
by expresspharma
Industry appreciate Cabinet sanction of Rs 15000 crores for pharma PLI scheme
The industry has appreciated the cabinet’s approval of Rs 15000 crores for the Production Linked Incentive (PLI) scheme in the pharma sector.
November 12, 2020
by expresspharma
Research finds 25 percent of drugs contain highly potent compounds
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.
September 27, 2020
by europeanpharmaceuticalreview
FDA Takes Actions to Help Lower Prescription Drug Prices
The U.S. Department of Health and Human Services and the U.S. Food and Drug Administration (FDA) took actions to help provide safe, effective, and more affordable drugs to American patients as part of the Safe Importation Action Plan ...
September 27, 2020
by americanpharmaceuticalreview
MSF urges government authorities to include patented drugs in upcoming NLEM
Also recommends inclusion of different formulations of insulin in the upcoming NLEM.
September 15, 2020
by expresspharma
US FDA releases guidance to detect and prevent nitrosamines in drugs
The US Food and Drug Administration (US FDA) has published guidance ‘Control of Nitrosamine Impurities in Human Drugs’ for immediate implementation.
September 3, 2020
by expresspharma
NPPA fixes retail prices of 30 formulations, rejects four applications
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 30 formulations under the provision of the Drugs (Prices Control) Order (DPCO) 2013.
August 24, 2020
by expresspharma